{
    "clinical_study": {
        "@rank": "127663", 
        "arm_group": {
            "arm_group_label": "haploidentical transplant", 
            "description": "transplant with haploidentical donor"
        }, 
        "brief_summary": {
            "textblock": "Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative\n      treatment for myelodysplastic syndrome (MDS), especially for advanced MDS (blast >5%).\n      However, many patients cannot find an HLA-matched donor. haploidentical donor is an\n      alternative stem cell source.\n\n      the study hypothesis: Haploidentical/mismatched hematopoietic stem cell transplantation can\n      improve the survival of patients with myelodysplastic syndrome"
        }, 
        "brief_title": "Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Advanced MDS Without Identical Sibling Donor", 
        "condition_browse": {
            "mesh_term": [
                "Myelodysplastic Syndromes", 
                "Preleukemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with MDS (1)intermediate-2 or high risk (2)low or intermediate-1 risk with\n             drug resistance or disease progression\n\n          -  without identical sibling donor\n\n        Exclusion Criteria:\n\n          -  Contraindication to HSCT\n\n          -  Pregnancy\n\n          -  Mental illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "2 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "patients with MDS:1)intermediate-2 or high risk 2)low or intermediate-1 risk, drug\n        resistance or disease progression"
            }
        }, 
        "enrollment": {
            "#text": "116", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01793675", 
            "org_study_id": "PUPH IRB [2013] (04)"
        }, 
        "intervention": {
            "arm_group_label": "haploidentical transplant", 
            "description": "patients with advanced MDS without identical sibling donor receive haploidentical transplant", 
            "intervention_name": "transplant with haploidentical donor", 
            "intervention_type": "Procedure", 
            "other_name": "haploidentical transplant"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510515"
                    }, 
                    "name": "Nanfang Hospital, Nanfang Medical University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tangshan", 
                        "country": "China", 
                        "state": "Hebei"
                    }, 
                    "name": "Hebei Tangshan Steel and Iron Company Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu"
                    }, 
                    "name": "Nanjing Gulou Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suzhou", 
                        "country": "China", 
                        "state": "Jiangsu"
                    }, 
                    "name": "Suzhou University The 1st Affiliated Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China", 
                        "state": "Sichuan"
                    }, 
                    "name": "The 3rd Army Medical University The 2nd Affiliated Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China", 
                        "state": "Sichuan"
                    }, 
                    "name": "Chongqing Medical University The 1st Affiliated Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100044"
                    }, 
                    "name": "Peking University People's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100781"
                    }, 
                    "name": "Aerospace center hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome", 
        "overall_official": {
            "affiliation": "Peking University People's Hospital", 
            "last_name": "xiaojun huang, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "number of participants with survival at one year", 
            "measure": "survival rate", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed for an expected average of one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01793675"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Peking University People's Hospital", 
            "investigator_full_name": "Xiaojun Huang", 
            "investigator_title": "Prof.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "number of participants with non-relapse mortality at one year", 
            "measure": "incidence of non-relapse mortality", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "source": "Peking University People's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking University People's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2003", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}